Dr. Brian Chapin, M.D.
Claim this profileU.T. MD Anderson Cancer Center
Area of expertise
Prostate Cancer
Brian Chapin, M.D. has run 3 trials for Prostate Cancer. Some of their research focus areas include:
Low Testosterone
Brian Chapin, M.D. has run 1 trial for Low Testosterone. Some of their research focus areas include:
Affiliated Hospitals
UT MD Anderson Cancer Center
MD Anderson In The Woodlands
Clinical Trials Brian Chapin, M.D. is currently running
177Lu rhPSMA-10.1 +/- Hormone Therapy
for Prostate Cancer
To learn if the proposed dose of 177Lu rhPSMA-10.1 is safe. Phase 2 will open if the Phase 1 dose is found to be safe. To learn about the safety and effects of 177Lu rhPSMA-10.1 alone and with androgen deprivation therapy (ADT) on patients with high-risk, localized prostate cancer before they have surgery to remove the disease.
Recruiting
1 award
Phase 1 & 2
19 criteria
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting
2 awards
Phase 3
30 criteria
More about Brian Chapin, M.D.
Clinical Trial Related
1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Brian Chapin, M.D. has experience with
- Degarelix
- Docetaxel
- 177Lu RhPSMA-10.1
- Abiraterone Acetate 250mg
- Apalutamide
- Luteinizing Hormone-releasing Hormone Agonist (LHRHa)
Breakdown of trials Brian Chapin, M.D. has run
Prostate Cancer
Low Testosterone
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian Chapin, M.D. specialize in?
Brian Chapin, M.D. focuses on Prostate Cancer and Low Testosterone. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are Stage I.
Is Brian Chapin, M.D. currently recruiting for clinical trials?
Yes, Brian Chapin, M.D. is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Brian Chapin, M.D. has studied deeply?
Yes, Brian Chapin, M.D. has studied treatments such as Degarelix, Docetaxel, 177Lu rhPSMA-10.1.
What is the best way to schedule an appointment with Brian Chapin, M.D.?
Apply for one of the trials that Brian Chapin, M.D. is conducting.
What is the office address of Brian Chapin, M.D.?
The office of Brian Chapin, M.D. is located at: U.T. MD Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the U.T. MD Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.